Yahoo
TSXV - Delayed Quote CAD

Kane Biotech Inc. (KNE.V)

0.0300 -0.0050 (-14.29%)
At close: October 30 at 2:57:25 PM EDT
View in AlphaSpace Currency in CAD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
38.7200
427.8690
2,080.8790
148.9800
156.7330
Cost of Revenue
38.7360
428.5090
1,208.7830
39.5100
44.7040
Gross Profit
-0.0160
-0.6400
872.0960
109.4700
112.0290
Operating Expense
2,675.1020
2,653.2080
4,795.0930
3,466.8560
3,569.6340
Operating Income
-2,675.1180
-2,653.8480
-3,922.9970
-3,357.3860
-3,457.6050
Net Non Operating Interest Income Expense
-166.7980
-223.7650
-540.5370
-1,209.3500
-801.2010
Other Income Expense
39.3270
48.3690
-7.8190
4.3910
237.1680
Pretax Income
-2,802.5890
-2,829.2440
-4,471.3530
-4,562.3450
-4,021.6380
Tax Provision
-99.9250
-108.0050
-1,310.2560
0
--
Net Income Common Stockholders
-2,702.6640
-2,721.2390
6,097.9420
-5,034.1030
-3,889.8920
Diluted NI Available to Com Stockholders
-2,702.6640
-2,721.2390
6,097.9420
-5,034.1030
-3,889.8920
Basic EPS
-0.02
-0.02
0.05
-0.04
-0.03
Diluted EPS
-0.02
-0.02
0.04
-0.04
-0.03
Basic Average Shares
161,293.9490
162,222.6990
133,905.6130
127,119.9570
120,702.0740
Diluted Average Shares
161,293.9490
162,222.6990
155,380.1230
127,119.9570
120,702.0740
Total Operating Income as Reported
-2,675.1180
-2,653.8480
-3,922.9970
-3,357.3860
-3,457.6050
Total Expenses
2,713.8380
3,081.7170
6,003.8760
3,506.3660
3,614.3380
Net Income from Continuing & Discontinued Operation
-2,702.6640
-2,721.2390
6,097.9420
-5,034.1030
-3,889.8920
Normalized Income
-2,760.8372
-2,767.7615
-3,223.8842
-4,327.0160
-4,069.8000
Interest Income
17.4130
18.9940
4.9430
5.6650
15.4630
Interest Expense
184.2110
242.7590
545.4800
1,215.0150
816.6640
Net Interest Income
-166.7980
-223.7650
-540.5370
-1,209.3500
-801.2010
EBIT
-2,618.3780
-2,586.4850
-3,925.8730
-3,347.3300
-3,204.9740
EBITDA
-2,517.7680
-2,423.7470
-3,707.4030
-3,108.7400
-2,947.2920
Reconciled Cost of Revenue
38.7360
428.5090
1,208.7830
39.5100
44.7040
Reconciled Depreciation
100.6100
162.7380
218.4700
238.5900
257.6820
Net Income from Continuing Operation Net Minority Interest
-2,702.6640
-2,721.2390
-3,229.4120
-4,326.3950
-4,087.5300
Total Unusual Items Excluding Goodwill
60.3240
48.3690
-7.8190
0.6210
-17.7300
Total Unusual Items
60.3240
48.3690
-7.8190
0.6210
-17.7300
Normalized EBITDA
-2,578.0920
-2,472.1160
-3,699.5840
-3,109.3610
-2,929.5620
Tax Rate for Calcs
0
0
0.0003
0
0
Tax Effect of Unusual Items
2.1508
1.8465
-2.2912
0
0
12/31/2022 - 10/1/2003

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: